搜索





搜索





市场行情
/
股票
/
stro
/

Sutro Biopharma Inc

STRO

添加自选

24.170USD

-0.650-2.62%

收盘 07-31 16:00（美东）报价延迟15分钟

400.51M总市值

亏损市盈率 TTM

Sutro Biopharma Inc

24.170

-0.650-2.62%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

STRO 利润表

您可以在这里找到Sutro Biopharma Inc的年度或季度收入报告，以深入了解Sutro Biopharma Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q1

FY2017Q4

FY2017Q3

营业总收入

-16.53%14.52M

-21.35%11.65M

13.77%9.69M

147.98%63.74M

33.76%17.40M

-86.98%14.81M

-49.66%8.52M

146.89%25.71M

2.64%13.01M

1217.44%113.72M

-32.70%16.92M

-62.94%10.41M

114.92%12.67M

-18.98%8.63M

195.26%25.15M

0.17%28.10M

-59.77%5.90M

28.70%10.65M

-52.21%8.52M

196.22%28.05M

104.98%14.66M

-26.78%8.28M

45.17%17.82M

-10.03%9.47M

-17.12%7.15M

-40.77%11.30M

56.67%12.28M

--10.53M

48.96%8.63M

372.43%19.09M

-55.22%7.84M

--5.79M

--4.04M

--17.50M

营业收入

-16.53%14.52M

-21.35%11.65M

13.77%9.69M

147.98%63.74M

33.76%17.40M

-86.98%14.81M

-49.66%8.52M

146.89%25.71M

2.64%13.01M

1217.44%113.72M

-32.70%16.92M

-62.94%10.41M

114.92%12.67M

-18.98%8.63M

195.26%25.15M

0.17%28.10M

-59.77%5.90M

28.70%10.65M

-52.21%8.52M

196.22%28.05M

104.98%14.66M

-26.78%8.28M

--17.82M

-10.03%9.47M

-17.12%7.15M

-38.67%11.30M

----

--10.53M

48.96%8.63M

356.24%18.43M

-60.43%6.92M

--5.79M

--4.04M

--17.50M

营业费用

-31.96%44.14M

-43.42%45.30M

-36.43%48.59M

-34.58%48.67M

-6.79%64.87M

13.46%80.07M

25.44%76.44M

31.45%74.39M

26.75%69.60M

21.98%70.57M

31.45%60.94M

19.20%56.59M

21.95%54.91M

26.62%57.85M

7.33%46.36M

25.42%47.48M

33.74%45.03M

37.95%45.69M

51.87%43.19M

46.23%37.85M

27.86%33.67M

26.96%33.12M

13.71%28.44M

6.92%25.89M

15.01%26.33M

16.66%26.09M

39.01%25.01M

--24.21M

30.86%22.89M

16.42%22.36M

-3.08%17.99M

--17.50M

--19.21M

--18.56M

研发费用

-29.16%36.55M

-48.42%36.64M

-35.83%39.85M

-38.21%38.33M

-9.28%51.60M

32.12%71.04M

36.00%62.11M

49.12%62.02M

44.36%56.88M

24.64%53.77M

44.00%45.67M

28.64%41.59M

31.37%39.40M

44.13%43.13M

19.22%31.71M

27.75%32.33M

32.92%29.99M

31.62%29.93M

37.40%26.60M

46.78%25.31M

28.05%22.56M

30.74%22.74M

14.58%19.36M

6.81%17.24M

16.07%17.62M

17.62%17.39M

33.66%16.90M

--16.14M

16.04%15.18M

-2.33%14.79M

-7.51%12.64M

--13.08M

--15.14M

--13.67M

折旧摊销及损耗

-32.74%1.28M

-13.06%1.62M

5.61%1.90M

6.15%1.90M

7.89%1.90M

7.91%1.87M

3.45%1.80M

3.41%1.79M

9.04%1.76M

13.29%1.73M

20.93%1.74M

23.91%1.73M

21.70%1.61M

16.20%1.53M

28.62%1.44M

24.73%1.40M

2.79%1.33M

12.20%1.31M

15.62%1.12M

5.76%1.12M

17.47%1.29M

-3.70%1.17M

-21.45%967.00K

-11.16%1.06M

-3.34%1.10M

7.22%1.22M

10.01%1.23M

--1.19M

-2.15%1.14M

-4.94%1.14M

-6.44%1.12M

--1.16M

--1.19M

--1.20M

营业利润

37.62%-29.61M

48.42%-33.66M

42.72%-38.90M

130.97%15.08M

16.12%-47.47M

-251.23%-65.26M

-54.31%-67.92M

-5.43%-48.69M

-33.98%-56.59M

187.67%43.15M

-107.52%-44.01M

-138.29%-46.18M

-7.93%-42.24M

-40.49%-49.22M

38.83%-21.21M

-97.64%-19.38M

-105.86%-39.13M

-41.03%-35.04M

-226.59%-34.67M

40.28%-9.80M

0.89%-19.01M

-68.06%-24.84M

16.63%-10.62M

-19.96%-16.42M

-34.45%-19.18M

-351.36%-14.78M

-25.38%-12.73M

---13.69M

-21.90%-14.27M

78.41%-3.27M

-853.71%-10.16M

---11.70M

---15.17M

---1.06M

净非营业利息收入（费用）

利息收入

-48.73%1.64M

-67.78%1.53M

-92.57%2.01M

-48.71%2.52M

-22.14%3.19M

4.45%4.76M

494.33%27.04M

72.80%4.91M

60.00%4.10M

37.25%4.56M

348.72%4.55M

1300.00%2.84M

1510.06%2.56M

1704.89%3.32M

830.28%1.01M

16.00%203.00K

-19.29%159.00K

-93.95%184.00K

-63.05%109.00K

-54.43%175.00K

-69.27%197.00K

275.19%3.04M

-69.40%295.00K

-65.84%384.00K

-45.49%641.00K

-28.51%810.00K

139.21%964.00K

--1.12M

2840.00%1.18M

1298.77%1.13M

550.00%403.00K

--40.00K

--81.00K

--62.00K

利息费用

-22.17%1.01M

-13.21%782.00K

--737.00K

-40.61%1.04M

-41.30%1.30M

-64.53%901.00K

----

-39.69%1.76M

-25.89%2.21M

408.00%2.54M

-1.76%2.74M

385.83%2.92M

326.57%2.99M

-28.57%500.00K

240.00%2.79M

-29.16%600.00K

-18.41%700.00K

16.67%700.00K

-64.61%820.00K

-71.34%847.00K

-18.75%858.00K

-26.56%600.00K

103.07%2.32M

139.85%2.96M

-8.97%1.06M

92.69%817.00K

174.94%1.14M

--1.23M

202.87%1.16M

12.47%424.00K

76.60%415.00K

--383.00K

--377.00K

--235.00K

股权收益

----

-100.00%0.00

-42.22%4.81M

152.62%3.68M

-33.14%7.89M

-80.15%694.00K

322.72%8.32M

-1341.92%-6.99M

558.88%11.81M

-22.02%3.50M

-186.38%-3.74M

105.27%563.00K

93.07%-2.57M

-84.95%4.48M

-91.15%4.33M

---10.69M

---37.14M

--29.78M

--48.86M

----

特殊收入（费用）

99.80%-42.00K

---4.39M

---9.56M

---18.42M

---21.04M

----

其他非经营性收入（费用）

-1.32%-9.47M

-9.86%-9.55M

-22.25%-9.67M

-32.40%-9.65M

-30.07%-9.34M

-40.34%-8.69M

-33.25%-7.91M

-1548.42%-7.29M

---7.18M

---6.19M

---5.94M

---442.00K

----

794.17%1.07M

62.22%-68.00K

----

--120.00K

---180.00K

税前利润

49.32%-38.50M

33.16%-46.84M

-16.54%-56.86M

76.01%-11.52M

-30.50%-75.97M

-249.53%-70.09M

-2.83%-48.79M

-25.11%-48.01M

-17.23%-58.21M

235.49%46.87M

-143.46%-47.45M

-63.21%-38.37M

-26.96%-49.66M

9.26%-34.59M

36.94%-19.49M

-282.18%-23.51M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

所得税

---15.00K

-103.48%-82.00K

--0.00

-325.00%-18.00K

----

-85.10%2.35M

-100.00%0.00

-94.70%8.00K

-100.00%0.00

--15.81M

--1.84M

-93.96%151.00K

--395.00K

--0.00

--2.50M

----

除税后利润

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

持续经营利润

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

归属于母公司的净利润

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

归属于普通股东的净利润

49.34%-38.48M

35.45%-46.76M

-16.54%-56.86M

76.05%-11.50M

-30.50%-75.97M

-333.20%-72.44M

1.01%-48.79M

-24.64%-48.02M

-16.31%-58.21M

189.80%31.07M

-152.89%-49.28M

-48.10%-38.52M

-27.97%-50.05M

9.26%-34.59M

36.94%-19.49M

-322.82%-26.01M

-28.83%-39.11M

35.97%-38.13M

-280.30%-30.90M

-120.59%-6.15M

-54.93%-30.36M

-302.62%-59.54M

232.74%17.14M

316.57%29.87M

-37.51%-19.59M

-890.56%-14.79M

-26.13%-12.91M

---13.79M

-18.30%-14.25M

90.27%-1.49M

-621.93%-10.24M

---12.05M

---15.34M

---1.42M

基本每股收益

-221.81%-2.94

-509.85%-5.35

-1026.60%-6.70

77.00%-0.14

3.49%-0.91

-272.32%-0.88

26.88%-0.59

7.40%-0.59

-11.13%-0.95

184.08%0.51

-118.45%-0.81

-15.25%-0.64

-1.33%-0.85

26.42%-0.61

44.39%-0.37

-315.25%-0.55

-27.18%-0.84

44.25%-0.82

-244.08%-0.67

-113.35%-0.13

21.71%-0.66

-130.68%-1.48

182.57%0.46

266.06%1.00

-35.54%-0.84

-880.04%-0.64

-25.59%-0.56

---0.60

-14.63%-0.62

90.56%-0.07

-600.06%-0.45

---0.54

---0.69

---0.06

稀释每股收益

-221.81%-2.94

-509.85%-5.35

-1026.60%-6.70

77.00%-0.14

3.49%-0.91

-272.32%-0.88

26.88%-0.59

7.40%-0.59

-11.13%-0.95

184.08%0.51

-118.45%-0.81

-15.25%-0.64

-1.33%-0.85

26.42%-0.61

44.39%-0.37

-315.25%-0.55

-27.18%-0.84

44.25%-0.82

-247.94%-0.67

-114.19%-0.13

21.71%-0.66

-130.68%-1.48

180.41%0.45

256.25%0.94

-35.54%-0.84

-880.04%-0.64

-25.59%-0.56

---0.60

-14.63%-0.62

90.56%-0.07

-600.06%-0.45

---0.54

---0.69

---0.06

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Sutro Biopharma Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 STRO 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Sutro Biopharma Inc 财年末的营收是多少？



Sutro Biopharma Inc 2025 财年营收为 102.48M，高于上一财年的62.04M。

Sutro Biopharma Inc 最近一个季度的营收是多少？



Sutro Biopharma Inc 最近一个季度的营收为 14.52M，同比增长 -16.53%。

Sutro Biopharma Inc 全年的净利润是多少？



Sutro Biopharma Inc 2025 财年净利润为 -191.09M。

Sutro Biopharma Inc 上一季度的净利润是多少？



Sutro Biopharma Inc 最近一个季度的净利润为 -38.48M。

Sutro Biopharma Inc 年度营业利润是多少？



Sutro Biopharma Inc 2025 财年的营业利润为 -104.95M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。